Evidence map›Paper›PMID 33177633›Full record

ArticleScientific reports2020

Diversity of secoiridoid glycosides in leaves of UK and Danish ash provide new insight for ash dieback management.

John D Sidda, Lijiang Song, Jack L Parker, David J Studholme, Christine Sambles, Murray Grant

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Early-Stage Growth Restriction ofMicroorganisms · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John D SiddaSchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK. j.sidda@warwick.ac.uk.
Lijiang SongDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
Jack L ParkerSchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
David J StudholmeSchool of Biosciences, University of Exeter, Exeter, EX4 4QD, UK.
Christine SamblesSchool of Biosciences, University of Exeter, Exeter, EX4 4QD, UK.
Murray GrantSchool of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK. m.grant@warwick.ac.uk.
University of Warwick · GBUniversity of Exeter · GB

Funding

Biotechnology and Biological Sciences Research Council BB/N021452/1Biotechnology and Biological Sciences Research Council BB/R018944/1
6 · The paper itself

Abstract

Secoiridoid glycosides are anti-feeding deterrents of the Oleaceae family recently highlighted as potential biomarkers in Danish ash trees to differentiate between those tolerant and susceptible to the fungal disease ash dieback. With the knowledge that emerald ash borer has recently entered Europe from Russia, and that extensive selection trials are ongoing in Europe for ash dieback tolerant European ash (Fraxinus excelsior), we undertook comprehensive screening of secoiridoid glycosides in leaf extracts of trees tolerant and susceptible to ash dieback sampled from sites in the UK and Denmark. Here we report an unexpected diversity of secoiridoid glycosides in UK trees and higher levels of secoiridoid glycosides in the UK sample group. While it is unlikely that secoiridoid glycosides generally can serve as reliable markers for ash dieback susceptibility, there are differences between tolerant and susceptible groups for specific secoiridoids. We predict that the high levels-and structural diversity-of secoiridoids present in the UK group may provide a robust reservoir of anti-feeding deterrents to mitigate future herbivore threats such as the Emerald ash borer.

Identifiers

PMID33177633
PMCPMC7658974
OpenAlexW3105983233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.